Redirecting T Cells to Ewing's Sarcoma Family of Tumors by a Chimeric NKG2D Receptor Expressed by Lentiviral Transduction or mRNA Transfection
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Redirecting T Cells to Ewing's Sarcoma Family of Tumors by a Chimeric NKG2D Receptor Expressed by Lentiviral Transduction or mRNA Transfection
Authors
Keywords
T cells, T cell receptors, Transfection, T helper cells, Flow cytometry, Cloning, Electroporation, Membrane receptor signaling
Journal
PLoS One
Volume 7, Issue 2, Pages e31210
Publisher
Public Library of Science (PLoS)
Online
2012-02-16
DOI
10.1371/journal.pone.0031210
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antigen Sensitivity of CD22-Specific Chimeric TCR Is Modulated by Target Epitope Distance from the Cell Membrane
- (2014) S. E. James et al. JOURNAL OF IMMUNOLOGY
- CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients
- (2011) Barbara Savoldo et al. JOURNAL OF CLINICAL INVESTIGATION
- Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor
- (2010) Y. Zhao et al. CANCER RESEARCH
- Cytotoxicity of Activated Natural Killer Cells against Pediatric Solid Tumors
- (2010) D. Cho et al. CLINICAL CANCER RESEARCH
- IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA
- (2010) Stephan Kloess et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia
- (2010) Jeffrey E. Rubnitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Mathematical Modeling of Chimeric TCR Triggering Predicts the Magnitude of Target Lysis and Its Impairment by TCR Downmodulation
- (2010) S. E. James et al. JOURNAL OF IMMUNOLOGY
- T Cells Engineered with a Cytomegalovirus-Specific Chimeric Immunoreceptor
- (2010) F. Full et al. JOURNAL OF VIROLOGY
- Adoptive cell therapy for the treatment of patients with metastatic melanoma
- (2009) Steven A Rosenberg et al. CURRENT OPINION IN IMMUNOLOGY
- The promise and potential pitfalls of chimeric antigen receptors
- (2009) Michel Sadelain et al. CURRENT OPINION IN IMMUNOLOGY
- ULBP6/RAET1L is an additional human NKG2D ligand
- (2009) Robert A. Eagle et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer
- (2009) K Birkholz et al. GENE THERAPY
- A high proportion of bone marrow T cells with regulatory phenotype (CD4+CD25hiFoxP3+) in Ewing sarcoma patients is associated with metastatic disease
- (2009) Peter Brinkrolf et al. INTERNATIONAL JOURNAL OF CANCER
- NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo
- (2009) Tadepally Lakshmikanth et al. JOURNAL OF CLINICAL INVESTIGATION
- Endosomes: A legitimate platform for the signaling train
- (2009) J. E. Murphy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chimeric NKG2D receptor–expressing T cells as an immunotherapy for multiple myeloma
- (2008) Amorette Barber et al. EXPERIMENTAL HEMATOLOGY
- Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer
- (2008) Sonja Textor et al. INTERNATIONAL JOURNAL OF CANCER
- NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways
- (2008) Dirk H.J. Verhoeven et al. MOLECULAR IMMUNOLOGY
- NKG2D ligands in tumor immunity
- (2008) N Nausch et al. ONCOGENE
- Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi‐modality therapy: A report from the Children's Oncology Group
- (2008) Patrick J. Leavey et al. PEDIATRIC BLOOD & CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation